{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:30:25Z","timestamp":1788975025652,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1053\/j.jfas.2018.08.041","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T17:10:55Z","timestamp":1546535455000},"page":"282-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers"],"prefix":"10.1053","volume":"58","author":[{"given":"Murat","family":"Kahraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhamit","family":"Misir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan Bilge","family":"Kizkapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozcamdalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5456-3699","authenticated-orcid":false,"given":"Erdal","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13300-012-0004-9","article-title":"Management of diabetic foot ulcers","volume":"3","author":"Alexiadou","year":"2012","journal-title":"Diabetes Ther"},{"key":"10.1053\/j.jfas.2018.08.041_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2923759","article-title":"Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome","volume":"2017","author":"Berlanga-Acosta","year":"2017","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0003","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"issue":"5 suppl","key":"10.1053\/j.jfas.2018.08.041_bib0004","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders. A clinical practice guideline (2006 revision)","volume":"45","author":"Frykberg","year":"2006","journal-title":"J Foot Ankle Surg."},{"issue":"24","key":"10.1053\/j.jfas.2018.08.041_bib0005","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1053\/j.jfas.2018.08.041_bib0006","first-page":"277","article-title":"Intralesional application of epidermal growth factor in limb-threatening ischemic diabetic foot ulcers","volume":"50","author":"Akta\u015f","year":"2016","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"7","key":"10.1053\/j.jfas.2018.08.041_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2929","article-title":"Dysregulation of wound healing mechanisms in diabetes and the importance of negative pressure wound therapy (NPWT)","volume":"33","author":"Khamaisi","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1053\/j.jfas.2018.08.041_bib0008","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ejvs.2014.03.005","article-title":"Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review","volume":"47","author":"Stoekenbroek","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.jfas.2018.08.041_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/256043","article-title":"Glucose toxic effects on granulation tissue productive cells: The diabetics\u2019 impaired healing","volume":"2013","author":"Berlanga-Acosta","year":"2013","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1053\/j.jfas.2018.08.041_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1742-481X.2011.00840.x","article-title":"Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment","volume":"8","author":"Berlanga-Acosta","year":"2011","journal-title":"Int Wound J"},{"issue":"3","key":"10.1053\/j.jfas.2018.08.041_bib0011","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1524-475x.2000.00192.x","article-title":"Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation","volume":"8","author":"Gibbs","year":"2000","journal-title":"Wound Repair Regen."},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0012","doi-asserted-by":"crossref","DOI":"10.1089\/wound.2016.0709","article-title":"Mechanical forces in cutaneous wound healing: emerging therapies to minimize scar formation","volume":"7","author":"Barnes","year":"2017","journal-title":"Adv Wound Care."},{"issue":"6","key":"10.1053\/j.jfas.2018.08.041_bib0013","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nmat3889","article-title":"Mechanical memory and dosing influence stem cell fate","volume":"13","author":"Yang","year":"2014","journal-title":"Nat Mater"},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SLA.0b013e318220b159","article-title":"Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies","volume":"254","author":"Gurtner","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"10.1053\/j.jfas.2018.08.041_bib0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00006534-198309000-00021","article-title":"Force required for wound closure and scar appearance","volume":"72","author":"Wray","year":"1983","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1053\/j.jfas.2018.08.041_bib0016","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/SAP.0b013e31819ae01b","article-title":"Wound edge microvascular blood flow: effects of negative pressure wound therapy using gauze or polyurethane foam","volume":"63","author":"Malmsj\u00f6","year":"2009","journal-title":"Ann Plast Surg"},{"issue":"suppl 2","key":"10.1053\/j.jfas.2018.08.041_bib0017","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1086\/383268","article-title":"Mechanical loading and off-loading of the plantar surface of the diabetic foot","volume":"39","author":"van Deursen","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1742-481X.2008.00561.x","article-title":"Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure","volume":"6","author":"Fern\u00e1ndez-Montequ\u00edn","year":"2009","journal-title":"Int Wound J"},{"issue":"3","key":"10.1053\/j.jfas.2018.08.041_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-481X.2006.00237.x","article-title":"Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds","volume":"3","author":"Acosta","year":"2006","journal-title":"Int Wound J"},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/08977194.2015.1031898","article-title":"Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers","volume":"33","author":"Dumantepe","year":"2015","journal-title":"Growth Factors"},{"key":"10.1053\/j.jfas.2018.08.041_bib0021","doi-asserted-by":"crossref","first-page":"28419","DOI":"10.3402\/dfa.v6.28419","article-title":"Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey","volume":"6","author":"Ertugrul","year":"2015","journal-title":"Diabet Foot Ankle"},{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0022","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7547\/15-056","article-title":"An assessment of intralesional epidermal growth factor for treating diabetic foot wounds: the first experiences in Turkey","volume":"107","author":"Ertugrul","year":"2017","journal-title":"J Am Podiatr Med Assoc."},{"issue":"14","key":"10.1053\/j.jfas.2018.08.041_bib0023","first-page":"21","article-title":"Reduction in the amputation rate with Hebeprot-P in the local treatment of diabetic foot","author":"Garcia Herrera","year":"2011","journal-title":"Rev Esp Invest Quir."},{"issue":"4","key":"10.1053\/j.jfas.2018.08.041_bib0024","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann Plast Surg."},{"issue":"5","key":"10.1053\/j.jfas.2018.08.041_bib0025","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3906\/sag-1703-153","article-title":"Intralesional epidermal growth factor therapy for diabetic foot ulcers: an evaluation of 15 cases","volume":"47","author":"Isikgoz-Tasbakan","year":"2017","journal-title":"Turk J Med Sci"},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0026","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0976-9668.136160","article-title":"Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients","volume":"5","author":"Singla","year":"2014","journal-title":"J Nat Sci Biol Med."},{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1531003512442093","article-title":"Epidermal growth factor in the treatment of diabetic foot ulcers: an update","volume":"24","author":"Tiaka","year":"2012","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0028","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2009.00594.x","article-title":"The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results","volume":"6","author":"Tuyet","year":"2009","journal-title":"Int Wound J"},{"issue":"19","key":"10.1053\/j.jfas.2018.08.041_bib0029","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2106\/JBJS.O.00030","article-title":"Scoring the SF-36 in orthopaedics: a brief guide","volume":"97","author":"Laucis","year":"2014","journal-title":"J Bone Jt Surg Am"},{"issue":"Suppl 11","key":"10.1053\/j.jfas.2018.08.041_bib0030","article-title":"Measures of foot function, foot health, and foot pain: American Academy of Orthopedic Surgeons Lower Limb Outcomes Assessment: Foot and Ankle Module (AAOS-FAM), Bristol Foot Score (BFS), Revised Foot Function Index (FFI-R), Foot Health Status Questionnaire","volume":"63","author":"Riskowski","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1053\/j.jfas.2018.08.041_bib0031","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0895-4356(91)90220-4","article-title":"The foot function index: a measure of foot pain and disability","volume":"44","author":"Budiman-Mak","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1053\/j.jfas.2018.08.041_bib0032","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4239\/wjd.v7.i7.153","article-title":"Diabetic foot disease: from the evaluation of the \u201cfoot at risk\u201d to the novel diabetic ulcer treatment modalities","volume":"7","author":"Amin","year":"2016","journal-title":"World J Diabetes."},{"issue":"4","key":"10.1053\/j.jfas.2018.08.041_bib0033","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1742-481X.2007.00344.x","article-title":"Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation","volume":"4","author":"Fern\u00e1ndez-Montequ\u00edn","year":"2007","journal-title":"Int Wound J"},{"issue":"5","key":"10.1053\/j.jfas.2018.08.041_bib0034","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1742-481X.2009.00622.x","article-title":"Epidermal growth factor in clinical practice: a review of its biological actions, clinical indications and safety implications","volume":"6","author":"Berlanga-Acosta","year":"2009","journal-title":"Int Wound J."},{"key":"10.1053\/j.jfas.2018.08.041_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2050-6511-14-44","article-title":"Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers","volume":"14","author":"Yera-Alos","year":"2013","journal-title":"BMC Pharmacol Toxicol."},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0036","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc12-1323","article-title":"Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor","volume":"36","author":"Valenzuela-Silva","year":"2013","journal-title":"Diabetes Care."},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0037","first-page":"11","article-title":"Clinical evolution of diabetic foot treatment with Heberprot-P or with the conventional method","volume":"11","author":"Gonzalez-Acosta","year":"2011","journal-title":"Rev Cuba Angiol Cir Vasc."},{"issue":"2","key":"10.1053\/j.jfas.2018.08.041_bib0038","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0309364615592705","article-title":"Foot deformities within the diabetic foot and their influence on biomechanics: a review of the literature","volume":"40","author":"Allan","year":"2016","journal-title":"Prosthet Orthot Int"},{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0039","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.22.1.157","article-title":"Causal pathways for incident lower - extremity ulcers in patients with diabetes from two settings","volume":"22","author":"Reiber","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.jfas.2018.08.041_bib0040","first-page":"65","article-title":"Foot ulcers in the diabetic patient, prevention and treatment","volume":"3","author":"Wu","year":"2007","journal-title":"Vasc Health Risk Manag"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725161830382X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725161830382X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:04:36Z","timestamp":1761023076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106725161830382X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S106725161830382X"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2018.08.041","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2018.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Foot and Ankle Surgeons. All rights reserved.","name":"copyright","label":"Copyright"}]}}